Biological Technologies
Funds biological science pushed toward protecting warfighters, not incremental upgrades to existing methods.
Biology keeps producing tools the military has barely started to use — from sensing to materials to human performance. DARPA's Biological Technologies Office exists to pull those tools in before anyone else does.
The office is soliciting proposals that use biological properties and processes to change what is possible for protecting warfighters. That is a wide brief on purpose: BTO does not name …
Proposals that use biological properties and processes to protect warfighters, spanning any biological technique or approach, but specifically excluding research that would only deliver evolutionary improvements on the existing state of practice.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
BudgetIndirect Costs in Grants: Rates, MTDC, and Examples
Understand indirect costs in grants, including direct vs indirect costs, negotiated rates, de minimis rates, MTDC, funder caps, and budget narrative implications.
More from DARPA
All grants from this funder →DARPA Quantum Benchmarking Initiative (QBI)
🇺🇸DARPA · United States
Funds United States quantum technology research aiming for scalable, error-corrected computing breakthroughs.
TTO Office Wide (OW) BAA 2025
🇺🇸DARPA · United States
Funds hardware and platform proposals across DARPA's Tactical Technology Office, covering four focus areas from rapid builds to disruptive concepts.
Information Processing Techniques Office Office-Wide
🇺🇸DARPA · United States
Funds ideas that do not fit any of DARPA's current information-processing programs or other open calls.
DARPA SBIR Phase I
🇺🇸DARPA · United States
Funds United States small businesses validating high-risk defense science concepts for practical technical development.
DARPA SBIR Phase II
🇺🇸DARPA · United States
Supports United States defense innovators building on validated concepts into advanced prototypes and field testing.
DARPA DSO Disruptioneering
🇺🇸DARPA · United States
Supports rapid United States exploratory defense research through fast-distributed projects and compact delivery agreements.
Similar grants
Browse the directory →
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Brain Behavior Quantification and Synchronization — Next Gen Sensor Technology Development
🇺🇸BRAIN Initiative · United States
Supports neural behavior-sensing technology development through translational cooperative projects.
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience
🇺🇸NIH · United States
Funds a minority-serving or IDeA-eligible institution to build a facility that makes and ships brain cell-targeting reagents to neuroscience labs.
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement
🇺🇸NIH · United States
Funds the planning of a clinical trial in oral, dental or craniofacial health, and then running it, as one phased award.
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders
🇺🇸NIH · United States
Funds IND-enabling studies and planning that take a gene-based therapy for an ultra-rare neurological or neuromuscular disorder toward its first human trial.
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain
🇺🇸NIH · United States
Funds optimizing an existing non-addictive pain drug or biologic candidate through IND filing and into a first human trial.